Marvin Slosman's most recent trade in InspireMD Inc was a trade of 10,330 Common Stock done at an average price of $2.4 . Disclosure was reported to the exchange on July 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| InspireMD Inc | Marvin Slosman | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 2.42 per share. | 30 Jul 2025 | 10,330 | 2,420,866 (66%) | 0% | 2.4 | 24,999 | Common Stock |
| InspireMD Inc | Marvin Slosman | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 563,499 | 1,852,119 | - | 0 | Restricted Stock Units | |
| InspireMD Inc | Marvin Slosman | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 215,405 | 682,811 | - | - | Options to purchase common stock (right to buy) | |
| InspireMD Inc | Marvin Slosman | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 1,045,150 | 1,288,620 | - | 0 | Restricted Stock Units | |
| InspireMD Inc | Marvin Slosman | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 348,380 | 467,406 | - | - | Options to purchase common stock (right to buy) | |
| InspireMD Inc | Marvin Slosman | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2021 | 146,567 | 243,470 | - | 0 | Restricted Stock Units | |
| InspireMD Inc | Marvin Slosman | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2021 | 48,855 | 48,855 | - | - | Options to purchase common stock (right to buy) | |
| InspireMD Inc | Marvin Slosman | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Apr 2021 | 600,000 | 1,052,556 | - | - | Option to Purchase Common Stock | |
| InspireMD Inc | Marvin Slosman | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 391,762 | 452,556 | - | - | Options (right to buy) | |
| InspireMD Inc | Marvin Slosman | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.62 per share. | 08 Feb 2021 | 40,320 | 1,453,538 (40%) | 1% | 0.6 | 24,998 | Common Stock |
| InspireMD Inc | Marvin Slosman | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Feb 2021 | 20,160 | 75,710 | - | - | Warrants |